Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-005096
Filing Date
2025-04-16
Accepted
2025-04-16 17:14:28
Documents
4
Period of Report
2025-04-16

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 213565
2 formpre14a_001.jpg GRAPHIC 8356
3 formpre14a_002.jpg GRAPHIC 372351
4 formpre14a_003.jpg GRAPHIC 442441
  Complete submission text file 0001641172-25-005096.txt   1348718
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41245 | Film No.: 25843565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)